Worth reading
59In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
0
Rights (number exercised during the month)Wording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of the 16th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
Intended allottee
EVO FUND (17,000 rights)
Terms of the stock acquisition rights
Exercise price
¥416 (for each trading day in July 2026) / Details of the adjustment provisions and adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 17,000 rights; unexercised at the end of the month preceding the month covered: 2,100 rights; unexercised at the end of the month covered: 2,100 rights
Most recent equity financing
Timing 1 August 2025 / Type Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 16th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Intended allottee | EVO FUND (17,000 rights) |
| Total number of issued shares | 8,383,200 shares (as of 30 June 2026, including 183 treasury shares) → Not disclosed |
| Exercise price | ¥416 (for each trading day in July 2026) / Details of the adjustment provisions and adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 17,000 rights; unexercised at the end of the month preceding the month covered: 2,100 rights; unexercised at the end of the month covered: 2,100 rights |
| Most recent equity financing | Timing 1 August 2025 / Type Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment provisions) / Amount Not disclosed |
Items this document does not state (22)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.No reason other than the absence of exercises was disclosed.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.